Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$87 Mln
P/E Ratio
--
P/B Ratio
21.95
Industry P/E
--
Debt to Equity
0.03
ROE
-2.85 %
ROCE
4.35 %
Div. Yield
0 %
Book Value
0.22
EPS
0.01
CFO
$-112.12 Mln
EBITDA
$-138.24 Mln
Net Profit
$-27.42 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Microbot Medical (MBOT)
| 86.61 | 22.94 | 5.03 | 135.49 | -28.34 | -18.07 | -47.56 |
|
BSE Sensex
| 2.39 | 4.18 | 4.86 | 8.78 | 11.89 | 20.62 | 11.13 |
|
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|---|---|
|
Microbot Medical (MBOT)
| -31.49 | -45.51 | -59.87 | 8.85 | -32.25 | 491.28 | -88.62 |
|
S&P Small-Cap 600
| 7.01 | 13.89 | -17.42 | 25.27 | 9.57 | 20.86 | -9.70 |
|
BSE Sensex
| 8.10 | 18.74 | 4.44 | 21.99 | 15.75 | 14.38 | 5.87 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
|---|---|---|---|---|
| 36.73 | 9,808.03 | 20.22 | 23.13 | |
| 284.42 | 8,956.09 | 22.08 | 58.42 | |
| 26.83 | 9,559.25 | -- | -28.77 | |
| 103.38 | 10,030.35 | 30.81 | 14.16 |
Microbot Medical Inc., a clinical-stage medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space in Israel and the United States. The company offers... LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, endovascular, and neurovascular operations. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system; and Emory University, in connection with autonomous robotics in endovascular procedures. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts. Address: 175 Derby Street, Hingham, MA, United States, 02043 Read more
Co-Founder, President, CEO & Chairman
Mr. Harel Gadot
Co-Founder, President, CEO & Chairman
Mr. Harel Gadot
Headquarters
Braintree, MA
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Microbot Medical Inc (MBOT) stood at $ 6 Mln as on 31-Dec-24
The share price of Microbot Medical Inc (MBOT) is $2.09 (NASDAQ) as of 23-Apr-2025 14:35 EDT. Microbot Medical Inc (MBOT) has given a return of -28.34% in the last 3 years.
Microbot Medical Inc (MBOT) has a market capitalisation of $ 87 Mln as on 22-Apr-2025. As per Value Research classification, it is a Small Cap company.
Since, TTM earnings of Microbot Medical Inc (MBOT) is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Microbot Medical Inc (MBOT) and enter the required number of quantities and click on buy to purchase the shares of Microbot Medical Inc (MBOT).
Microbot Medical Inc., a clinical-stage medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space in Israel and the United States. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, endovascular, and neurovascular operations. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system; and Emory University, in connection with autonomous robotics in endovascular procedures. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts. Address: 175 Derby Street, Hingham, MA, United States, 02043
The CEO & director of Mr. Harel Gadot. is Microbot Medical Inc (MBOT), and CFO & Sr. VP is Mr. Harel Gadot.
There is no promoter pledging in Microbot Medical Inc (MBOT).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
1,012
|
|
|
990
|
|
|
974
|
|
|
896
|
| Microbot Medical Inc. (MBOT) | Ratios |
|---|---|
|
Return on equity(%)
|
4.53
|
|
Operating margin(%)
|
--
|
|
Net Margin(%)
|
--
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Microbot Medical Inc (MBOT) was $0 Mln.
$0.04
(
